{"id":"W2284212734","doi":"10.1016/j.urology.2016.01.015","title":"Pioglitazone: No Longer a Worry for Bladder Cancer?","year":2016,"lang":"en","type":"letter","venue":"Urology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pioglitazone; Cancer registry; Population; Internal medicine; Bladder cancer; Cancer; Endometrial cancer; Oncology; Gynecology; Diabetes mellitus; Type 2 diabetes; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002185852,0.0006957955,0.001439179,0.0006192689,0.002953749,0.003049494,0.001249714,0.03623967,0.007737874],"category_scores_gemma":[0.01770254,0.000475202,0.001270292,0.000709337,0.003149516,0.005289133,0.001490676,0.03807628,0.00432528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002506385,"about_ca_system_score_gemma":0.002035236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001728594,"about_ca_topic_score_gemma":0.003531036,"domain_scores_codex":[0.9981918,0.0005876956,0.0002412305,0.0002171875,0.0005257981,0.0002363149],"domain_scores_gemma":[0.9952452,0.002467165,0.0004296382,0.0002132583,0.0004652258,0.001179606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002795166,0.0001179442,0.001331437,0.0002218105,0.00006744063,0.008579644,0.0001212935,0.0001473362,0.0004571649,0.006812065,0.9389156,0.04294872],"study_design_scores_gemma":[0.0003855275,0.0003144763,0.001297047,0.0006519484,0.00008454655,0.01191558,0.0005400138,0.000377657,0.0003298431,0.03086554,0.9531126,0.0001251841],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.000298415,0.005088861,0.00006220579,0.979929,0.01345511,0.000002553591,0.00001694311,0.00001447778,0.001132394],"genre_scores_gemma":[0.007335196,0.009284918,0.000312897,0.8877506,0.08931782,0.00001535308,0.00003221308,0.00001911659,0.005931768],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.03623967,"threshold_uncertainty_score":0.02588576,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01082756370884456,"score_gpt":0.2587175968759107,"score_spread":0.2478900331670662,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}